Acute Myeloid Leukemia News and Research

RSS
Acute Myeloid Leukemia (AML) is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approximately 9,000 deaths from AML occurred in the U.S. during 2007. AML is generally a disease of older adults, and the median age of a patient diagnosed with AML is about 67 years. A majority of elderly patients are not considered candidates for standard induction therapy or decline therapy, resulting in an acute need for new treatment options.
Study provides new insight into how 'trash bag of the cell' traps and seals off waste

Study provides new insight into how 'trash bag of the cell' traps and seals off waste

Study reveals role of RUNX proteins in DNA repair

Study reveals role of RUNX proteins in DNA repair

Scientists identify stress hormone as key factor in failure of immune system to inhibit leukemia

Scientists identify stress hormone as key factor in failure of immune system to inhibit leukemia

FOXM1 contributes to treatment failure in acute myeloid leukemia

FOXM1 contributes to treatment failure in acute myeloid leukemia

New discovery could pave way for improved leukemia treatment

New discovery could pave way for improved leukemia treatment

Combination of arsenic and existing leukemia drug may combat cancer

Combination of arsenic and existing leukemia drug may combat cancer

Ivosidenib receives FDA approval to treat acute myeloid leukemia patients with IDH1 mutation

Ivosidenib receives FDA approval to treat acute myeloid leukemia patients with IDH1 mutation

Answer to decades-old mystery may allow some children to avoid bone marrow transplantation

Answer to decades-old mystery may allow some children to avoid bone marrow transplantation

Pfizer announces FDA approval of biosimilar to Neupogen

Pfizer announces FDA approval of biosimilar to Neupogen

FDA approves first drug for treatment of adult AML patients with specific genetic mutation

FDA approves first drug for treatment of adult AML patients with specific genetic mutation

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

Researchers map family trees of cancer cells to understand how AML responds to new drug

Researchers map family trees of cancer cells to understand how AML responds to new drug

Researchers uncover molecular drivers of  a deadly pediatric cancer

Researchers uncover molecular drivers of a deadly pediatric cancer

Scientists discover new way to predict healthy individuals at risk of developing AML

Scientists discover new way to predict healthy individuals at risk of developing AML

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

Streamlining and translating basic science discoveries into the clinic

Streamlining and translating basic science discoveries into the clinic

Researchers show how mutant CALR protein triggers cancer

Researchers show how mutant CALR protein triggers cancer

New guidelines recommend newborns with Down’s syndrome to receive leukemia test

New guidelines recommend newborns with Down’s syndrome to receive leukemia test

Researchers identify racial differences in breast cancer immune microenvironment

Researchers identify racial differences in breast cancer immune microenvironment

Protein inhibitor drug found to be safe and effective in treating patients with acute myeloid leukemia

Protein inhibitor drug found to be safe and effective in treating patients with acute myeloid leukemia